Fluorescent markers such as EpCAM and cytokeratin may identify only a subset of tumor cells, particularly those undergoing epithelial-to-mesenchymal transition (EMT), during which epithelial markers are frequently downregulated (Mikolajczyk et al. 2011, Yu et al. 2013). This evidence concerns the gene EPCAM and neoplasm.